DME
Clinical trials for DME explained in plain language.
Never miss a new study
Get alerted when new DME trials appear
Sign up with your email to follow new studies for DME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye implant could slash injections for diabetes-related vision loss
Disease control Recruiting nowThis study tests an eye implant called EYP-1901 that slowly releases medication to treat diabetic macular edema, a condition that causes vision loss in people with diabetes. About 240 adults with this eye condition will receive either the implant or standard aflibercept injection…
Matched conditions: DME
Phase: PHASE3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New eye drug could cut injection frequency for diabetic vision loss
Disease control Recruiting nowThis phase 3 study tests whether a new drug, EYP-1901, works as well as the standard treatment aflibercept for diabetic macular edema, a condition that causes vision loss. About 240 adults with DME will receive either EYP-1901 or aflibercept injections. The goal is to see if EYP-…
Matched conditions: DME
Phase: PHASE3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC